BiondVax Pharmaceuticals Ltd. (BVXV)

Last Price: 3.23 (2020-11-27)

Company Description

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-31.60M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) -135.18%
Current Ratio (Most Recent Fiscal Quarter) 6.48
Quick Ratio (Most Recent Fiscal Quarter) 6.48
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-2.88
Earnings per Share (Most Recent Fiscal Quarter) $-1.12
Earnings per Share (Most Recent Fiscal Year) $-3.60
Diluted Earnings per Share (Trailing 12 Months) $-3.02
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 11.52M
Free Float 10.83M
Market Capitalization $37.21M
Average Volume (Last 20 Days) 0.71M
Beta (Past 60 Months) 2.63
Percentage Held By Insiders (Latest Annual Proxy Report) 6.03%
Percentage Held By Institutions (Latest 13F Reports) 4.14%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%